US has wasted more than 82 million COVID-19 vaccine doses: report
The Biden administration said the COVID-19 vaccine could be available to young children as Pfizer and BioNTech have requested they undergo a three-dose regimen
FDA panel greenlights Novavax COVID-19 vaccine
FDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves.
1st COVID-19 vaccine dose possible for kids under 5 as soon as June 21, White House says
The Biden administration says children under 5 may be able to get their first COVID-19 vaccination doses as soon as June 21, if federal regulators authorize shots for the age group as expected.
New COVID-19 vaccine option Novavax hopes to win over FDA, Americans
Americans may soon get a new COVID-19 vaccine option — a more traditional kind of shot known as a protein vaccine.
Vaccines don't always protect infected from 'long Covid,' new research shows
Research in U.S. veterans provides fresh evidence that long COVID-19 can happen even after breakthrough infections following vaccination.
COVID-19 vaccine for kids under 5: Pfizer says 3 small doses offer strong protection
Pfizer says it plans to give the data to U.S. regulators later this week. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
3 Air Force cadets who refused COVID-19 vaccine won't be commissioned
A fourth cadet who had refused the vaccine until about a week ago decided to be vaccinated and will graduate and become an Air Force officer.
CDC expands COVID-19 booster recommendation to include kids 5 to 11
U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11.
Vaccines could have prevented at least 318K COVID-19 deaths in the US, study says
Of the 1 million American lives lost to COVID-19, hundreds of thousands of those deaths could have been averted by vaccines, researchers say.
FDA approves Pfizer COVID-19 booster for children ages 5 to 11
Pfizer’s COVID-19 booster shot for U.S. kids ages 5 to 11 has been approved by the FDA. Next, it will need the CDC’s final sign-off.
4 Air Force cadets may not graduate due to vaccine refusal
It's the only military academy, so far, where cadets may not graduate for refusing the COVID-19 vaccine.
Bill Gates tests positive for COVID-19: 'I'm fortunate to be vaccinated and boosted'
Billionaire philanthropist Bill Gates tested positive for COVID-19, he announced Tuesday on Twitter.
J&J COVID-19 vaccine distribution restricted due to blood clot risk, FDA says
U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Pfizer hopes to submit COVID-19 vaccine data for youngest kids in weeks
Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
Why are vaccines still important if so many kids have already had COVID-19?
A recent CDC report estimated that 75% of U.S. kids have likely had COVID-19. Here’s why experts say vaccines are still important, despite having recovered from a previous infection.
Moderna asks FDA to approve COVID-19 vaccine for kids under 6
Children under 5 are the only group in the U.S. not yet eligible for a COVID-19 vaccination.
Metro Atlanta clinic offers free gift card to those who get COVID-19 vaccine
Efforts are still underway to increase vaccination rates among underserved people in metro Atlanta. The Healing Bridge Clinic in Peachtree City provides free medical care to people who can’t afford it otherwise.
Church spring festival comes with COVID cash incentive
Salem Bible Church was one of the first churches in DeKalb County to distribute free COVID-19 tests to the public.
Moderna hopes to offer updated COVID-19 booster for latest variant this fall
Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant.
COVID-19 booster: Pfizer to seek extra shot for healthy kids 5 to 11
Pfizer said new data shows its kid-sized COVID-19 booster could help healthy elementary-aged children rev up virus-fighting antibodies and plans to seek authorization soon.